Mettler-Toledo International
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. The last earnings update was 77 days ago. More info.
Add to Portfolio Compare Print
MTD Share Price and Events
7 Day Returns
1 Year Returns
MTD Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Mettler-Toledo International (MTD) | 0.3% | 4% | 19% | 29.6% | 104.2% | 210.7% |
| US Life Sciences | -1.4% | -1.1% | 8% | 25.2% | 82.8% | 118.8% |
| US Market | 0.9% | 4.6% | 10.9% | 9.6% | 39% | 47.2% |
1 Year Return vs Industry and Market
- MTD outperformed the Life Sciences industry which returned 25.2% over the past year.
- MTD outperformed the Market in United States of America which returned 9.6% over the past year.
Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Mettler-Toledo International
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Mettler-Toledo International.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 10 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 9.1% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Life Sciences Unlevered Beta | Simply Wall St/ S&P Global | 1.05 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.054 (1 + (1- 21%) (5.7%)) |
1.068 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.07 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.068 * 5.96%) |
9.09% |
Discounted Cash Flow Calculation for NYSE:MTD using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Mettler-Toledo International is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 9.09%) |
|
|---|---|---|---|
| 2019 | 516.78 | Analyst x7 | 473.70 |
| 2020 | 556.58 | Analyst x6 | 467.66 |
| 2021 | 597.93 | Analyst x2 | 460.53 |
| 2022 | 632.83 | Est @ 5.84% | 446.78 |
| 2023 | 663.87 | Est @ 4.9% | 429.63 |
| 2024 | 692.10 | Est @ 4.25% | 410.57 |
| 2025 | 718.37 | Est @ 3.8% | 390.63 |
| 2026 | 743.34 | Est @ 3.48% | 370.52 |
| 2027 | 767.52 | Est @ 3.25% | 350.68 |
| 2028 | 791.28 | Est @ 3.1% | 331.40 |
| Present value of next 10 years cash flows | $4,132.09 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $791.28 × (1 + 2.73%) ÷ (9.09% – 2.73%) |
$12,774.59 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $12,774.59 ÷ (1 + 9.09%)10 |
$5,350.18 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $4,132.09 + $5,350.18 |
$9,482.27 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $9,482.27 / 24.84 |
$381.76 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $381.76 |
| Current discount | Discount to share price of
$731.01
= -1 x ($731.01 - $381.76) / $381.76 |
-91.5% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Mettler-Toledo International is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Mettler-Toledo International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Mettler-Toledo International's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in USD | $20.33 |
| NYSE:MTD Share Price ** | NYSE (2019-04-25) in USD | $731.01 |
| United States of America Life Sciences Industry PE Ratio | Median Figure of 21 Publicly-Listed Life Sciences Companies | 35.6x |
| United States of America Market PE Ratio | Median Figure of 3,081 Publicly-Listed Companies | 18.28x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Mettler-Toledo International.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NYSE:MTD Share Price ÷ EPS (both in USD) = 731.01 ÷ 20.33 |
35.96x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Mettler-Toledo International is overvalued based on earnings compared to the US Life Sciences industry average.
- Mettler-Toledo International is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does
Mettler-Toledo International's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 35.96x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 10 Analysts |
8.3%per year |
| United States of America Life Sciences Industry PEG Ratio | Median Figure of 19 Publicly-Listed Life Sciences Companies | 2.78x |
| United States of America Market PEG Ratio | Median Figure of 2,113 Publicly-Listed Companies | 1.57x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 35.96x ÷ 8.3% |
4.35x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Mettler-Toledo International is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Mettler-Toledo International's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in USD | $23.68 |
| NYSE:MTD Share Price * | NYSE (2019-04-25) in USD | $731.01 |
| United States of America Life Sciences Industry PB Ratio | Median Figure of 39 Publicly-Listed Life Sciences Companies | 4.77x |
| United States of America Market PB Ratio | Median Figure of 5,185 Publicly-Listed Companies | 1.92x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NYSE:MTD Share Price ÷ Book Value per Share (both in USD) = 731.01 ÷ 23.68 |
30.88x |
* Primary Listing of Mettler-Toledo International.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Mettler-Toledo International is overvalued based on assets compared to the US Life Sciences industry average.
Value checks
We assess Mettler-Toledo International's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Life Sciences industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Life Sciences industry average (and greater than 0)? (1 check) Mettler-Toledo International has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Mettler-Toledo International's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- Mettler-Toledo International's earnings growth is positive but not above the United States of America market average.
- Mettler-Toledo International's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NYSE:MTD Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 10 Analysts | 8.3% |
| NYSE:MTD Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 10 Analysts | 4.5% |
| United States of America Life Sciences Industry Earnings Growth Rate | Market Cap Weighted Average | 14.8% |
| United States of America Life Sciences Industry Revenue Growth Rate | Market Cap Weighted Average | 6.9% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 13.5% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-12-31 | 3,368 | 742 | 659 | 5 |
| 2020-12-31 | 3,199 | 687 | 604 | 10 |
| 2019-12-31 | 3,034 | 641 | 556 | 10 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 2,936 | 565 | 513 |
| 2018-09-30 | 2,896 | 532 | 408 |
| 2018-06-30 | 2,860 | 528 | 387 |
| 2018-03-31 | 2,791 | 525 | 377 |
| 2017-12-31 | 2,725 | 516 | 376 |
| 2017-09-30 | 2,657 | 505 | 437 |
| 2017-06-30 | 2,609 | 504 | 433 |
| 2017-03-31 | 2,563 | 487 | 411 |
| 2016-12-31 | 2,508 | 461 | 384 |
| 2016-09-30 | 2,472 | 444 | 370 |
| 2016-06-30 | 2,426 | 425 | 357 |
| 2016-03-31 | 2,399 | 410 | 355 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
All data from Mettler-Toledo International Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-12-31 | 28.12 | 28.12 | 28.12 | 1.00 |
| 2020-12-31 | 25.06 | 25.07 | 25.04 | 2.00 |
| 2019-12-31 | 22.31 | 22.33 | 22.30 | 2.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2018-12-31 | 20.33 |
| 2018-09-30 | 16.10 |
| 2018-06-30 | 15.17 |
| 2018-03-31 | 14.72 |
| 2017-12-31 | 14.62 |
| 2017-09-30 | 16.89 |
| 2017-06-30 | 16.63 |
| 2017-03-31 | 15.65 |
| 2016-12-31 | 14.49 |
| 2016-09-30 | 13.81 |
| 2016-06-30 | 13.20 |
| 2016-03-31 | 12.98 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Mettler-Toledo International is expected to make outstanding use of shareholders’ funds in the future (Return on Equity greater than 40%).
Future performance checks
We assess Mettler-Toledo International's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Mettler-Toledo International has a total score of 2/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Mettler-Toledo International performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Mettler-Toledo International's year on year earnings growth rate has been positive over the past 5 years.
- Mettler-Toledo International's 1-year earnings growth exceeds its 5-year average (36.3% vs 7.2%)
- Mettler-Toledo International's earnings growth has not exceeded the US Life Sciences industry average in the past year (36.3% vs 43.3%).
Earnings and Revenue History
All data from Mettler-Toledo International Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 2,935.59 | 512.61 | 806.60 | 141.07 |
| 2018-09-30 | 2,895.69 | 408.40 | 808.70 | 138.15 |
| 2018-06-30 | 2,859.65 | 386.70 | 814.88 | 135.51 |
| 2018-03-31 | 2,791.31 | 376.81 | 802.48 | 132.78 |
| 2017-12-31 | 2,725.05 | 375.97 | 790.86 | 128.31 |
| 2017-09-30 | 2,656.72 | 436.77 | 773.45 | 126.14 |
| 2017-06-30 | 2,608.52 | 433.15 | 757.18 | 124.08 |
| 2017-03-31 | 2,563.15 | 411.16 | 749.36 | 122.20 |
| 2016-12-31 | 2,508.26 | 384.37 | 735.56 | 119.20 |
| 2016-09-30 | 2,472.09 | 369.95 | 721.82 | 120.92 |
| 2016-06-30 | 2,425.65 | 357.47 | 709.68 | 120.50 |
| 2016-03-31 | 2,399.42 | 355.44 | 696.69 | 119.59 |
| 2015-12-31 | 2,395.45 | 352.82 | 700.81 | 119.08 |
| 2015-09-30 | 2,419.34 | 350.64 | 710.18 | 119.29 |
| 2015-06-30 | 2,444.29 | 346.78 | 721.13 | 119.93 |
| 2015-03-31 | 2,471.06 | 343.24 | 729.43 | 122.26 |
| 2014-12-31 | 2,485.98 | 338.24 | 728.58 | 123.30 |
| 2014-09-30 | 2,472.81 | 327.23 | 721.58 | 122.57 |
| 2014-06-30 | 2,435.39 | 316.56 | 708.53 | 121.27 |
| 2014-03-31 | 2,405.24 | 311.60 | 698.86 | 118.14 |
| 2013-12-31 | 2,378.97 | 306.09 | 692.69 | 116.35 |
| 2013-09-30 | 2,352.01 | 300.57 | 688.28 | 113.75 |
| 2013-06-30 | 2,338.88 | 298.42 | 685.86 | 112.60 |
| 2013-03-31 | 2,330.48 | 291.06 | 682.41 | 111.56 |
| 2012-12-31 | 2,341.53 | 290.85 | 684.03 | 112.53 |
| 2012-09-30 | 2,332.60 | 280.50 | 693.02 | 114.64 |
| 2012-06-30 | 2,355.16 | 276.51 | 707.83 | 116.82 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Whilst Mettler-Toledo International made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%), this is metric is skewed due to its high level of debt.
- Mettler-Toledo International used its assets more efficiently than the US Life Sciences industry average last year based on Return on Assets.
- Mettler-Toledo International has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Mettler-Toledo International's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Life Sciences industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Mettler-Toledo International has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Mettler-Toledo International's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Mettler-Toledo International's finances.
The net worth of a company is the difference between its assets and liabilities.
- Mettler-Toledo International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Mettler-Toledo International's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Mettler-Toledo International Company Filings, last reported 3 months ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 590.06 | 1,034.69 | 178.11 |
| 2018-09-30 | 531.62 | 1,044.65 | 137.45 |
| 2018-06-30 | 532.43 | 1,072.47 | 183.19 |
| 2018-03-31 | 560.75 | 993.60 | 98.95 |
| 2017-12-31 | 547.28 | 979.85 | 148.69 |
| 2017-09-30 | 512.98 | 1,069.21 | 169.09 |
| 2017-06-30 | 461.92 | 969.39 | 146.33 |
| 2017-03-31 | 439.85 | 963.69 | 164.89 |
| 2016-12-31 | 434.94 | 894.03 | 158.67 |
| 2016-09-30 | 500.52 | 847.80 | 146.13 |
| 2016-06-30 | 491.96 | 714.21 | 114.65 |
| 2016-03-31 | 543.33 | 699.25 | 110.60 |
| 2015-12-31 | 580.46 | 589.63 | 98.89 |
| 2015-09-30 | 586.35 | 622.79 | 123.30 |
| 2015-06-30 | 654.25 | 631.37 | 149.31 |
| 2015-03-31 | 666.13 | 529.03 | 75.36 |
| 2014-12-31 | 719.60 | 451.95 | 85.26 |
| 2014-09-30 | 848.94 | 488.56 | 126.31 |
| 2014-06-30 | 907.71 | 471.07 | 111.01 |
| 2014-03-31 | 923.60 | 470.54 | 115.80 |
| 2013-12-31 | 935.05 | 418.34 | 111.87 |
| 2013-09-30 | 847.64 | 406.89 | 92.22 |
| 2013-06-30 | 811.10 | 468.16 | 120.22 |
| 2013-03-31 | 800.22 | 447.37 | 93.21 |
| 2012-12-31 | 827.22 | 396.93 | 101.70 |
| 2012-09-30 | 798.24 | 424.58 | 105.37 |
| 2012-06-30 | 774.97 | 467.92 | 134.77 |
- Mettler-Toledo International's level of debt (175.4%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (44.8% vs 175.4% today).
- Debt is well covered by operating cash flow (54.6%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 20x coverage).
Financial health checks
We assess Mettler-Toledo International's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Mettler-Toledo International has a total score of 3/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Mettler-Toledo International's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Mettler-Toledo International
shares you are expected to receive
$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Mettler-Toledo International's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Mettler-Toledo International's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
| United States of America Life Sciences Industry Average Dividend Yield | Market Cap Weighted Average of 7 Stocks | 0.4% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2008 Stocks | 2.4% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.6% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2021-12-31 | 0.00 | 2.00 |
| 2020-12-31 | 0.00 | 3.00 |
| 2019-12-31 | 0.00 | 3.00 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Mettler-Toledo International has not reported any payouts.
- Unable to verify if Mettler-Toledo International's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Mettler-Toledo International's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Mettler-Toledo International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Mettler-Toledo International has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| COMPENSATION | $7,069,870 |
| AGE | 51 |
| TENURE AS CEO | 11.3 years |
CEO Bio
Mr. Olivier A. Filliol serves as Chief Executive Officer and President of Mettler-Toledo S.A.E. Mr. Filliol has been Chief Executive Officer and President of Mettler-Toledo Inc. (Canada) since January 2008. Mr. Filliol has been the Chief Executive Officer and President of Mettler-Toledo (Schweiz) GmbH since January 2008. Mr. Filliol has been the Chief Executive Officer and President of Mettler-Toledo International Inc., since January 1, 2008 Mr. Filliol joined Mettler-Toledo Inc. (Canada) in June 1998 as General Manager of its North American checkweighing operations. He served as Head of Process Analytics and Head of Global Sales Service & Marketing at Mettler-Toledo International Inc., from April 2004 to December 2007 and from April 2004 to December 2007 respectively. From June 1998 to June 1999, Mr. Filliol served as General Manager of Hi-Speed Checkweigher Inc., a subsidiary of Mettler Toledo International Inc. in New York. He was a Strategy Consultant with the international consulting firm Bain & Company working in the Geneva, Paris, London and Sydney offices. Mr. Filliol has been Director of Mettler-Toledo International Inc. since January 1, 2009. Mr. Filliol has been a Director of Mettler-Toledo (Schweiz) GmbH since 2009. He has been Director of Mettler-Toledo Inc. (Canada) since January 2009. He holds Masters and Ph.D. in Business Administration from the University of St. Gallen, Switzerland and has completed executive education at the Business School of Stanford University.
CEO Compensation
- Olivier's compensation has been consistent with company performance over the past year.
- Olivier's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Mettler-Toledo International management team in years:
- The average tenure for the Mettler-Toledo International management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team
Olivier Filliol
President
$7M
51
11.3 yrs
Shawn Vadala
Chief Financial Officer
$2M
49
5.3 yrs
Marc de La Guéronnière
Head of European & North American Market Organizations
$2M
54
5 yrs
Simon Kirk
Head of Product Inspection
$1M
58
7.3 yrs
Peter Aggersbjerg
Head of Laboratory
$1M
50
1.3 yrs
Mary Finnegan
Head of Investor Relations & Treasurer
Proia Roe
General Counsel & Secretary
47
Christian Magloth
Head of Human Resources
52
8.3 yrs
Michael Heidingsfelder
Head of Industrial Division
$1M
57
7 yrs
Richard Wong
Head of Asia/Pacific Market Organizations
10.3 yrs
Board of Directors Tenure
Average tenure and age of the Mettler-Toledo International board of directors in years:
- The average tenure for the Mettler-Toledo International board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors
Robert Spoerry
Chairman
$869K
63
20.9 yrs
Olivier Filliol
President
$7M
51
10.3 yrs
Tom Salice
Presiding Director
$288K
58
Hans Maerki
Independent Director
$141K
72
16.6 yrs
Elisha Finney
Independent Director
$229K
57
1.4 yrs
Wah-Hui Chu
Independent Director
$216K
66
12.3 yrs
Mike Kelly
Independent Director
$233K
61
10.8 yrs
Connie Harvey
Independent Director
$216K
56
3.8 yrs
Richard Francis
Independent Director
$219K
50
2.9 yrs
Who owns this company?
Recent Insider Trading
- Mettler-Toledo International insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 26. Feb 19 | Sell | Robert Spoerry | Individual | 22. Feb 19 | 25. Feb 19 | -27,112 | $685.01 | $-18,412,520 | ||
| 22. Feb 19 | Sell | Robert Spoerry | Individual | 20. Feb 19 | 21. Feb 19 | -35,000 | $674.70 | $-23,537,567 | ||
| 20. Feb 19 | Sell | Robert Spoerry | Individual | 15. Feb 19 | 19. Feb 19 | -25,000 | $672.44 | $-16,766,079 | ||
| 15. Feb 19 | Sell | Robert Spoerry | Individual | 13. Feb 19 | 14. Feb 19 | -16,713 | $673.18 | $-11,188,808 | ||
| 13. Feb 19 | Sell | Robert Spoerry | Individual | 11. Feb 19 | 12. Feb 19 | -21,175 | $667.69 | $-14,085,694 | ||
| 13. Feb 19 | Sell | Gerhard Keller | Individual | 11. Feb 19 | 11. Feb 19 | -250 | $664.50 | $-166,125 | ||
| 20. Nov 18 | Sell | Shawn Vadala | Individual | 16. Nov 18 | 16. Nov 18 | -149 | $598.18 | $-89,129 | ||
Management checks
We assess Mettler-Toledo International's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Mettler-Toledo International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
At US$732, Is It Time To Put Mettler-Toledo International Inc. (NYSE:MTD) On Your Watch List?
led the NYSE gainers with a relatively large price hike in the past couple of weeks. … As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock … However, could the stock still be trading at a relatively cheap price?
Simply Wall St - – Full articleWhat Should You Know About Mettler-Toledo International Inc.'s (NYSE:MTD) Future?
Based on Mettler-Toledo International Inc.'s (NYSE:MTD) earnings update in December 2018,. … analyst consensus outlook appear cautiously optimistic, … with earnings expected to grow by 8.2% in the upcoming year
Simply Wall St - – Full articleRead This Before You Buy Mettler-Toledo International Inc. (NYSE:MTD) Because Of Its P/E Ratio
We'll look at Mettler-Toledo International Inc.'s (NYSE:MTD) P/E ratio and reflect on what it tells us about the company's share price. … Based on the last twelve months, Mettler-Toledo International's P/E ratio is 33.5. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleMettler-Toledo International Shareholders Have Enjoyed An Impressive 173% Share Price Gain
One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). … During five years of share price growth, Mettler-Toledo International achieved compound earnings per share (EPS) growth of 15% per year. … This EPS growth is slower than the share price growth of 22% per year, over the same period.
Simply Wall St - – Full articleHave Insiders Been Selling Mettler-Toledo International Inc. (NYSE:MTD) Shares This Year?
So we'll take a look at whether insiders have been buying or selling shares in Mettler-Toledo International Inc. … Mettler-Toledo International Insider Transactions Over The Last Year. … When an insider sells below the current price, it does tend to make us wonder about the current valuation
Simply Wall St - – Full articleWhat Is Mettler-Toledo International Inc.'s (NYSE:MTD) Share Price Doing?
saw a decent share price growth in the teens level on the NYSE over the last few months. … With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price? … Let’s take a look at Mettler-Toledo International’s outlook and value based on the most recent financial data to see if the opportunity still exists.
Simply Wall St - – Full articleDoes Mettler-Toledo International Inc.'s (NYSE:MTD) CEO Pay Reflect Performance?
First, this article will compare CEO compensation with compensation at other large companies. … How Does Olivier Filliol's Compensation Compare With Similar Sized Companies. … has a market capitalization of US$15b, and pays its CEO total annual compensation worth US$7.3m.
Simply Wall St - – Full articleBoasting A 77% Return On Equity, Is Mettler-Toledo International Inc (NYSE:MTD) A Top Quality Stock?
We'll use ROE to examine Mettler-Toledo International Inc (NYSE:MTD), by way of a worked example. … That means that for every $1 worth of shareholders' equity, it generated $0.77 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleDo You Know What Mettler-Toledo International Inc's (NYSE:MTD) P/E Ratio Means?
We'll show how you can use Mettler-Toledo International Inc's (NYSE:MTD) P/E ratio to inform your assessment of the investment opportunity. … Mettler-Toledo International has a price to earnings ratio of 35.66, based on the last twelve months. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleWhat Is Mettler-Toledo International Inc's (NYSE:MTD) Share Price Doing?
received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to $617.94 at one point, and dropping to the lows of $554.45. … A question to answer is whether Mettler-Toledo International's current trading price of $573.59 reflective of the actual value of the? … Let’s take a look at Mettler-Toledo International’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change
Simply Wall St - – Full articleCompany Info
Description
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters and sensors, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a PC-based laboratory embedded software platform. The company’s industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of networked scales and software, and stand-alone scales for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community. The company markets its products through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Columbus, Ohio.
Details
| Name: | Mettler-Toledo International Inc. |
| MTD | |
| Exchange: | NYSE |
| Founded: | 1991 |
| $18,156,896,556 | |
| 24,838,096 | |
| Website: | http://www.mt.com |
| Address: |
Mettler-Toledo International Inc. 1900 Polaris Parkway, Columbus, Ohio, 43240, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NYSE | MTD | Common Stock | New York Stock Exchange | US | USD | 14. Nov 1997 | |
| DB | MTO | Common Stock | Deutsche Boerse AG | DE | EUR | 14. Nov 1997 | |
| LSE | 0K10 | Common Stock | London Stock Exchange | GB | USD | 14. Nov 1997 | |
| BMV | MTD * | Common Stock | Bolsa Mexicana de Valores | MX | MXN | 14. Nov 1997 |
Number of employees
Current staff
Industry
| Life Sciences Tools and Services | |
| Pharmaceuticals & Biotech |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/26 01:41 |
| End of day share price update: | 2019/04/25 00:00 |
| Last estimates confirmation: | 2019/04/23 |
| Last earnings filing: | 2019/02/08 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
